In recent years, microdosing has become an increasingly discussed topic, posing significant challenges to the underwriting of life insurance applications. While not yet widespread, microdosing is gaining mainstream awareness and warrants the careful attention of agents during the interview and application process. Microdosing involves the ingestion of very small quantities of a psychedelic substance to achieve specific benefits, including improved mood, mental health, creativity, energy, cognition, and awareness. Substances such as LSD, Psilocybin, mescaline, ketamine, and others are consumed ...